Skip to content

Multi-center retrospective study of radical hysterectomy versus radiotherapy as a primary treatment for stage IB2-IIB non-squamous cell carcinoma of the uterine cervix. (SGSG-015)

Multi-center retrospective study of radical hysterectomy versus radiotherapy as a primary treatment for stage IB2-IIB non-squamous cell carcinoma of the uterine cervix. (SGSG-015) - Surgery versus radiotherapy as a primary treatment for stage IB2-IIB non-SCC of uterine cervix. (SGSG-015)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016285
Enrollment
400
Registered
2015-01-20
Start date
2013-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-squamous cell carcinoma of uterine cervix

Interventions

None listed

Sponsors

Sankai Gynecology Study Group
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Stage IB2-IIB patients with non-squamous cell carcinoma of uteriine cervix received primary curative treatment between 2004 and 2009.

Exclusion criteria

Exclusion criteria: Small cell carcinoma and undifferentiated carcinoma

Design outcomes

Primary

MeasureTime frame
Loco-regional control rate according to the primary treatment (radical hysterectomy versus radiation therapy)

Countries

Japan

Contacts

Public ContactAtsumi Kojima

Iwate Medical University Obstetrics and Gynecology

akojima@iwate-med.ac.jp019-651-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026